AIPT stock forecast
Our latest prediction for Precision Therapeutics, Inc.'s stock price was made on the May 24, 2019 when the stock price was at 0.56$.
In the short term (2weeks), AIPT's stock price should outperform the market by 6.93%. During that period the price should oscillate between -10.41% and +23.22%.
In the medium term (3months), AIPT's stock price should outperform the market by 12.27%. During that period the price should oscillate between -24.31% and +73.69%.Get email alerts
About Precision Therapeutics, Inc.
Precision Therapeutics, Inc. engages in the manufacture and distribution of healthcare products, and provision of related services. The company offers STREAMWAY System, which is an automated system for the collection and disposal of infectious fluids from surgical and other medical procedures. It operates through the Medical Device and Consumable Products segments. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -0.85$ per share.
The book value per share is None$
Three months stock forecastMay 24, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|